Comorbidities in chronic obstructive pulmonary disease patients

被引:1
作者
Ali, Ahmed Abd El-Rahman [1 ]
El Wahsh, Rabab Abd El Razek [1 ]
El Dandouh, Samy Sayed-Ahmed [1 ]
Fouad, Ahmed Abdalla Ahmed [1 ]
机构
[1] Menoufia Univ, Fac Med, Dept Chest, Menoufia, Egypt
来源
EGYPTIAN JOURNAL OF CHEST DISEASES AND TUBERCULOSIS | 2020年 / 69卷 / 02期
关键词
Charlson Comorbidity Index; comorbidity; chronic obstructive pulmonary disease; GLOBAL MORTALITY; LUNG-FUNCTION; CO-MORBIDITY; RISK-FACTORS; SMOKING; OUTCOMES; BURDEN; ASTHMA;
D O I
10.4103/ejcdt.ejcdt_141_19
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background Chronic obstructive pulmonary disease (COPD) is characterized by persistent airflow limitation and respiratory symptoms. Several diseases co-exist with COPD. Tobacco smoking is an important risk factor for comorbidities. Comorbidities potentiate the morbidity and the mortality of COPD. Aim of the work The aim of this study was to study the different comorbidities in COPD patients and assess their impact on COPD patients. Patients and methods This is an observational cohort study carried out at El-Mahalla El-Kobra Chest Hospital on 188 COPD patients between June 2018 and June 2019. All patients underwent spirometry, categorized into spirometric severity grades and ABCD GOLD groups according to GOLD 2019. Demographics data, smoking index, BMI, comorbidities, and the presence of dyspnea were collected. The Charlson Comorbidity Index was calculated. Results One hundred eighty-eight patients were analyzed. 69.68% of the participants were men; the mean age was 57.5 years. More than 70% of the patients had severe and very severe COPD. More than 70% of the patients were GOLD C and GOLD D. More than 95% of the studied patients had different comorbidities and the most frequent comorbidities were hypertension (54.78%), diabetes mellitus (36.70%), anemia (28.72%), gastroesophageal reflux disease (17.02%), ischemic heart disease (11.17%), and arrhythmia (10.36%). There was a significant difference among the ABCD GOLD groups in age, smoking index, Charlson Comorbidity Index, and the prevalence of anemia and gastroesophageal reflux disease. Conclusions COPD patients had different comorbidities, which have a negative impact on the severity of the disease.
引用
收藏
页码:310 / 315
页数:6
相关论文
共 31 条
  • [1] Adm EI, 2016, THESIS
  • [2] Characterisation of COPD heterogeneity in the ECLIPSE cohort
    Agusti, Alvar
    Calverley, Peter M. A.
    Celli, Bartolome
    Coxson, Harvey O.
    Edwards, Lisa D.
    Lomas, David A.
    MacNee, William
    Miller, Bruce E.
    Rennard, Steve
    Silverman, Edwin K.
    Tal-Singer, Ruth
    Wouters, Emiel
    Yates, Julie C.
    Vestbo, Jorgen
    [J]. RESPIRATORY RESEARCH, 2010, 11
  • [3] Ali A., 2009, THESIS
  • [4] [Anonymous], 1960, BMJ
  • [5] [Anonymous], 2011, THESIS
  • [6] Prevalence of gastroesophageal reflux disease in patients with asthma and chronic obstructive pulmonary disease
    Bor, Serhat
    Kitapcioglu, Gul
    Solak, Zeynep Aytemur
    Ertilav, Muhittin
    Erdinc, Munevver
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2010, 25 (02) : 309 - 313
  • [7] Reduced lung function and risk of atrial fibrillation in The Copenhagen City Heart Study
    Buch, P
    Friberg, J
    Scharling, H
    Lange, P
    Prescott, E
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2003, 21 (06) : 1012 - 1016
  • [8] Comparison of the 2017 and 2015 Global Initiative for Chronic Obstructive Lung Disease Reports Impact on Grouping and Outcomes
    Cabrera Lopez, Carlos
    Casanova Macario, Ciro
    Marin Triguo, Jose Maria
    de-Torres, Juan P.
    Sicilia Torres, Rebeca
    Maria Gonzalez, Jesus
    Polverino, Francesca
    Divo, Miguel
    Pinto Plata, Victor
    Zulueta, Javier J.
    Celli, Bartolome
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197 (04) : 463 - 469
  • [9] A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION
    CHARLSON, ME
    POMPEI, P
    ALES, KL
    MACKENZIE, CR
    [J]. JOURNAL OF CHRONIC DISEASES, 1987, 40 (05): : 373 - 383
  • [10] Prognostic evaluation of COPD patients: GOLD 2011 versus BODE and the COPD comorbidity index COTE
    de Torres, Juan P.
    Casanova, Ciro
    Marin, Jose M.
    Pinto-Plata, Victor
    Divo, Miguel
    Zulueta, Javier J.
    Berto, Juan
    Zagaceta, Jorge
    Sanchez-Salcedo, Pablo
    Cabrera, Carlos
    Carrizo, Santiago
    Cote, Claudia
    Celli, Bartolome R.
    [J]. THORAX, 2014, 69 (09) : 799 - 804